In summary, the results show that scFvNLDC-145-HER2-vaccinated mice developed antibodies that recognize epitopes expressed by D2F2/E2 cells and thus may also confer protection against tumor growth in vivo. The gene discussed is ERBB2; the disease is neoplasm.